Search Clinical Trials
596,159 trials
ID
Status
Phase
Title
Sponsor
NCT07737834
Clinical, Radiographic and Volumetric Evaluation of the Entire Papilla Preservation Technique With and Without Connective Tissue Graft in the Treatment of Periodontal Intraosseous Defects.Medical University of WarsawNot Yet RecruitingNot Applicable
NCT07737834Not Yet Recruiting
Not Applicable
Clinical, Radiographic and Volumetric Evaluation of the Entire Papilla Preservat...Medical University of War...
NCT07737444
Association of Lipoprotein(a) With Postoperative Atrial FibrillationAnthony TangNot Yet Recruiting
NCT07737444Not Yet Recruiting
—
Association of Lipoprotein(a) With Postoperative Atrial FibrillationAnthony Tang
NCT07737093
Acapella vs Flutter Devices for Improving Breathing and Lung Function After LobectomyRiphah International UniversityRecruitingNot Applicable
NCT07737093Recruiting
Not Applicable
Acapella vs Flutter Devices for Improving Breathing and Lung Function After Lobe...Riphah International Univ...
NCT07736833
Efficacy of Liquid Phase Concentrated Growth Factors as an Adjunct to EDTA in the Treatment of Recession Type 1 Defect With Free Gingival GraftTanta UniversityCompletedNot Applicable
NCT07736833Completed
Not Applicable
Efficacy of Liquid Phase Concentrated Growth Factors as an Adjunct to EDTA in th...Tanta University
NCT07736911
Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.Fu Jen Catholic University HospitalRecruitingPhase 3
NCT07736911Recruiting
Phase 3
Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Es...Fu Jen Catholic Universit...
NCT07736807
Early Electroacupuncture for Post-TURP LUTSZhongda HospitalNot Yet RecruitingNot Applicable
NCT07736807Not Yet Recruiting
Not Applicable
Early Electroacupuncture for Post-TURP LUTSZhongda Hospital
NCT07736404
A Study of SYH2082 Injection in Healthy ParticipantsCSPC Ouyi Pharmaceutical Co., Ltd.Active Not RecruitingPhase 1
NCT07736404Active Not Recruiting
Phase 1
A Study of SYH2082 Injection in Healthy ParticipantsCSPC Ouyi Pharmaceutical...
NCT07736612
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic CancerZhejiang UniversityNot Yet RecruitingPhase 1
NCT07736612Not Yet Recruiting
Phase 1
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With...Zhejiang University
NCT07736937
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian CancerTubulis GmbHRecruitingPhase 1
NCT07736937Recruiting
Phase 1
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-...Tubulis GmbH
NCT07736209
Effects of Heavy Back-Squat PAPE on Jump and Repeated Sprint Performance in Trained Soccer PlayersIstanbul University - CerrahpasaCompletedNot Applicable
NCT07736209Completed
Not Applicable
Effects of Heavy Back-Squat PAPE on Jump and Repeated Sprint Performance in Trai...Istanbul University - Cer...
NCT07735611
Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)Case Comprehensive Cancer CenterNot Yet RecruitingNot Applicable
NCT07735611Not Yet Recruiting
Not Applicable
Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)Case Comprehensive Cancer...
NCT07736716
Arthroscopic Infrapatellar Fat Pad Release and Mesenchymal Stem Cell MobilizationAnkara City Hospital BilkentCompletedNot Applicable
NCT07736716Completed
Not Applicable
Arthroscopic Infrapatellar Fat Pad Release and Mesenchymal Stem Cell Mobilizatio...Ankara City Hospital Bilk...
NCT07736690
Perioperative Topical Nepafenac After Epiretinal Membrane SurgeryAnkara Yildirim Beyazıt UniversityCompletedPhase 4
NCT07736690Completed
Phase 4
Perioperative Topical Nepafenac After Epiretinal Membrane SurgeryAnkara Yildirim Beyazıt U...
NCT07736898
Exploring the Effectiveness of Multimodal Interactive Chatbot-Assisted Learning on Nursing Documentation Competence Among Novice NursesNational Taiwan University HospitalActive Not RecruitingNot Applicable
NCT07736898Active Not Recruiting
Not Applicable
Exploring the Effectiveness of Multimodal Interactive Chatbot-Assisted Learning...National Taiwan Universit...
NCT07735832
Emotional Regulation and Stress Coping Program for Nursing Students During Clinical PlacementsUniversidad VillanuevaNot Yet RecruitingNot Applicable
NCT07735832Not Yet Recruiting
Not Applicable
Emotional Regulation and Stress Coping Program for Nursing Students During Clini...Universidad Villanueva
NCT07736066
Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart SurgeryHUINNO Co., LtdCompletedNot Applicable
NCT07736066Completed
Not Applicable
Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart SurgeryHUINNO Co., Ltd
NCT07735689
Evaluate the Value of Modified Shock Index in Predicting the Incidence of Cardiovascular Events After Non-cardiac Surgery in Cardiac PatientsFujian Medical University Union HospitalNot Yet Recruiting
NCT07735689Not Yet Recruiting
—
Evaluate the Value of Modified Shock Index in Predicting the Incidence of Cardio...Fujian Medical University...
NCT07736144
Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia SyndromeJuan JiaoRecruitingNot Applicable
NCT07736144Recruiting
Not Applicable
Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia Syndr...Juan Jiao
NCT07736092
Perioperative Transcranial Photobiomodulation and Delayed Neurocognitive Recovery in Older PatientsPeking University First HospitalNot Yet RecruitingNot Applicable
NCT07736092Not Yet Recruiting
Not Applicable
Perioperative Transcranial Photobiomodulation and Delayed Neurocognitive Recover...Peking University First H...
NCT07735728
A First-in-Human Study of ZE66-0205 in Healthy VolunteersEilean TherapeuticsNot Yet RecruitingPhase 1
NCT07735728Not Yet Recruiting
Phase 1
A First-in-Human Study of ZE66-0205 in Healthy VolunteersEilean Therapeutics
Result Breakdown
Not yet recruiting9 (45%)
Completed5 (25%)
Recruiting4 (20%)
Active, not recruiting2 (10%)
not_applicable12 (60%)
Phase 14 (20%)
Not Specified2 (10%)
Phase 31 (5%)
Phase 41 (5%)